| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630b360599ea5cf4b5bcbc0c6c0a3e2d |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
1993-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3399a7645f2a205ae38e304d9bf4e3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc7a1e9dfc9b8d675b8463a738ae3ebf |
| publicationDate |
1994-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H069401-A |
| titleOfInvention |
Argatroban formulation for ophthalmology |
| abstract |
(57) [Summary] [Purpose] The purpose is to prevent postoperative anterior chamber fibrin formation after intraocular surgery such as retinal and vitreous surgery, cataract surgery and glaucoma surgery. The present invention provides a method for preventing fibrin formation in the anterior chamber, which comprises administering argatroban into the anterior chamber. The present invention also provides a perfusate, an eye drop and an infusion for carrying out the method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006008696-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004083201-A1 |
| priorityDate |
1992-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |